Additionally, elevated levels of Fibroblast Growth Factor 23 (FGF23) are linked to an increased risk of PAD, with a hazard ratio of 2.26 for individuals in the highest quartile of FGF23 levels compared to the lowest (30). This evidence concerns the gene FGF23 and peripheral arterial disease.